Christophe Bellanger - Publications

Accuracy of automated 3D biliary tract reconstruction compared to ERCP to assess Bismuth-Corlette classification in patients with perihilar cholangiocarcinoma.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 15, 2025

Gastrointestinal complications of immune checkpoint Inhibitor therapy.

Journal: Presse medicale (Paris, France : 1983)

Published: April 10, 2025

Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors.

Journal: Clinics and research in hepatology and gastroenterology

Published: November 20, 2023

WallFlex® and Evolution® Duodenal Stents Have Similar Efficacy but Different Safety for Malignant Gastric Outlet Obstruction.

Journal: Digestive diseases and sciences

Published: March 06, 2023

Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors.

Journal: Alimentary pharmacology & therapeutics

Published: October 05, 2022

Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.

Journal: Alimentary pharmacology & therapeutics

Published: March 16, 2021

Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colon.

Journal: EXCLI journal

Published: February 28, 2021

Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 13, 2020

Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.

Journal: Alimentary pharmacology & therapeutics

Published: May 09, 2020